Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study

BACKGROUND: In August 2002, the antifungal prophylaxis algorithm for neutropenic hematology/oncology (NHO) patients at the Medical Center was changed from conventional amphotericin (AMB) to an azole (AZ) based regimen (fluconazole [FLU] in low-risk and voriconazole [VOR] in high-risk patients). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Amy, Choe, Lan, Inciardi, John, Yuen, Courtney, Martin, Thomas, Guglielmo, B Joseph
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925090/
https://www.ncbi.nlm.nih.gov/pubmed/17605773
http://dx.doi.org/10.1186/1471-2334-7-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925090/
https://www.ncbi.nlm.nih.gov/pubmed/17605773
http://dx.doi.org/10.1186/1471-2334-7-70

Ejemplares similares